This article has been updated to include share price and details.

NEW YORK, Nov. 4 (GenomeWeb News) - Shares in Bruker BioSciences were down 6.27 percent at $3.13 in late-afternoon trade--six cents above their 52-week high--despite modest third-quarter revenue.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.